269 related articles for article (PubMed ID: 20157216)
1. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer.
Resel Folkersma L; San José Manso L; Galante Romo I; Moreno Sierra J; Olivier Gómez C
Urology; 2012 Dec; 80(6):1328-32. PubMed ID: 23063057
[TBL] [Abstract][Full Text] [Related]
3. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
4. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells predict survival in patients with metastatic prostate cancer.
Moreno JG; Miller MC; Gross S; Allard WJ; Gomella LG; Terstappen LW
Urology; 2005 Apr; 65(4):713-8. PubMed ID: 15833514
[TBL] [Abstract][Full Text] [Related]
7. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
Kurihara T; Itoi T; Sofuni A; Itokawa F; Tsuchiya T; Tsuji S; Ishii K; Ikeuchi N; Tsuchida A; Kasuya K; Kawai T; Sakai Y; Moriyasu F
J Hepatobiliary Pancreat Surg; 2008; 15(2):189-95. PubMed ID: 18392713
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
[TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
[TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
[TBL] [Abstract][Full Text] [Related]
16. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
[TBL] [Abstract][Full Text] [Related]
17. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
[TBL] [Abstract][Full Text] [Related]
18. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer.
Nakamura S; Yagata H; Ohno S; Yamaguchi H; Iwata H; Tsunoda N; Ito Y; Tokudome N; Toi M; Kuroi K; Suzuki E
Breast Cancer; 2010 Jul; 17(3):199-204. PubMed ID: 19649686
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of circulating tumor cells in prostate cancer patients.
Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
[TBL] [Abstract][Full Text] [Related]
20. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
